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doi:10.1152/ajpregu.00797.2007.—We tested the hypothesis that va-
gal withdrawal plays a role in the rapid (phase I) cardiopulmonary
response to exercise. To this aim, in five men (24.6  3.4 yr, 82.1 
13.7 kg, maximal aerobic power 330  67 W), we determined
beat-by-beat cardiac output (Q̇), oxygen delivery (Q̇aO2), and breath-
by-breath lung oxygen uptake (V̇O2) at light exercise (50 and 100 W)
in normoxia and acute hypoxia (fraction of inspired O2  0.11),
because the latter reduces resting vagal activity. We computed Q̇ from
stroke volume (Qst, by model flow) and heart rate (fH, electrocardi-
ography), and Q̇aO2 from Q̇ and arterial O2 concentration. Double
exponentials were fitted to the data. In hypoxia compared with
normoxia, steady-state fH and Q̇ were higher, and Qst and V̇O2 were
unchanged. Q̇aO2 was unchanged at rest and lower at exercise. During
transients, amplitude of phase I (A1) for V̇O2 was unchanged. For fH,
Q̇ and Q̇aO2, A1 was lower. Phase I time constant (1) for Q̇aO2 and V̇O2
was unchanged. The same was the case for Q̇ at 100 W and for fH at
50 W. Qst kinetics were unaffected. In conclusion, the results do not
fully support the hypothesis that vagal withdrawal determines phase I,
because it was not completely suppressed. Although we can attribute
the decrease in A1 of fH to a diminished degree of vagal withdrawal
in hypoxia, this is not so for Qst. Thus the dual origin of the phase I
of Q̇ and Q̇aO2, neural (vagal) and mechanical (venous return increase
by muscle pump action), would rather be confirmed.
cardiovascular response
ALTHOUGH OUR KNOWLEDGE of the central (neural) control of the
cardiovascular system at the exercise steady state is quite well
established (19, 42, 57), how the circulatory readjustments
upon exercise onset occur and match the increase in pulmonary
oxygen uptake (V̇O2) is less understood, as are the mechanisms
underlying this matching. The kinetics of V̇O2 at exercise onset
were seen for a long time as reflecting essentially the metabolic
adaptations in the working muscles (15, 31, 33). Some authors,
however, soon identified two components of the V̇O2 kinetics:
1) a rapid, almost immediate phase (phase I) (5, 54, 55), which
they attributed to an immediate increase in cardiac output (Q̇)
at exercise start; and 2) a subsequent slower phase (phase II),
to which they restricted the influence of muscle metabolic
adjustments. The strongest support to this view came from the
demonstration that the kinetics of Q̇ (12, 13, 16, 60) and
arterial O2 flow (Q̇aO2) (27) are very rapid.
The concept of a close correspondence between V̇O2 and
muscle O2 consumption was further undermined by the recent
demonstration that, upon the onset of light exercise, the V̇O2
kinetics are faster than the kinetics of muscle O2 consumption
estimated from the monoexponential decrease in phosphocre-
atine concentration (7, 14, 43). This would imply dissociation
of the kinetics of V̇O2 and muscle O2 consumption, which
should respond to different control mechanisms.
Our postulate is that the V̇O2 kinetics are dictated by the
regulation of the systemic cardiovascular response to exercise,
whereas the metabolic regulatory processes dictate only the
kinetics of muscle O2 consumption. In this context, Fagraeus
and Linnarsson (18) proposed that the rapid heart rate (fH)
changes in exercise transients “are mediated through a with-
drawal of vagal tone” (termed “vagal withdrawal” from this
point), which can be defined as a quasi-immediate inhibition of
vagal action on the sinus node at exercise start. In fact, they
showed that the rapid phase of the fH kinetics was cancelled out
under vagal blockade, whereas -adrenergic blockade with
propranolol did not affect it. In this study, we tested the
hypothesis that vagal withdrawal also plays a major role in
determining phase I kinetics of Q̇, Q̇aO2, and V̇O2. If this is so,
then in acute normobaric hypoxia, wherein reduced vagal
activity (8, 26) and increased sympathetic activity at rest have
been postulated (21, 26, 58, 59), phase I would be either absent
or at least less intense compared with normoxia.
With this hypothesis in mind, the aim of this study was to
perform simultaneous determinations of the phase I kinetics of
fH, Q̇, Q̇aO2, and V̇O2 upon exercise onset in normoxia and acute
normobaric hypoxia. Such an experiment was never carried out
in the past, to the best of our knowledge.
METHODS
Subjects. Five healthy, nonsmoking young male subjects took part
in the experiments. They were 24.6  3.4 yr old, 1.79  0.09 m tall,
and weighed 82.1  13.7 kg. Their maximal O2 consumption and
maximal aerobic mechanical power in normoxia were 4.42  0.62
l/min and 330  67 W, respectively. The corresponding values in
hypoxia were 3.41  0.83 l/min and 255  78 W, respectively. All
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subjects were preliminarily informed of all procedures and risks
associated with the experimental testing. Informed consent was ob-
tained from each volunteer, who was aware of his right to withdraw
from the study at any time without jeopardy. The study was conducted
in accordance with the Declaration of Helsinki. The protocol was
approved by the Comités d’Ethique des Hôpitaux Universitaires
Genevois (Switzerland). The experiments were carried out at Geneva,
Switzerland.
Measurements. V̇O2 was determined on a breath-by-breath basis.
The time course of O2 and CO2 partial pressures throughout the
respiratory cycles were continuously monitored with a mass spec-
trometer (Balzers Prisma, Balzers, Liechtenstein) calibrated against
gas mixtures of known composition. The inspiratory and expiratory
ventilations were measured by an ultrasonic flowmeter (Spiroson;
Ecomedics, Duernten, Switzerland) calibrated with a 3-liter syringe.
The alignment of traces was corrected for the time delay between the
flowmeter and the mass spectrometer. Breath-by-breath V̇O2 and CO2
output (V̇CO2) were then computed off-line by means of a modified
version of Grønlund’s algorithm (9). Software purposely written
under the Labview developing environment (Labview 5.0; National
Instruments, Austin, TX) was used. The characteristics and physio-
logical implications of Grønlund’s algorithm are widely discussed
elsewhere (9, 11, 27).
fH and arterial oxygen saturation (SaO2) were continuously mea-
sured using electrocardiography (Elmed ETM 2000; Heiligenhaus,
Germany) and fingertip infrared oximetry (Ohmeda 2350; Finapres,
Englewood, CO), respectively. In hypoxia, SaO2 data were corrected
for time delay between lungs and fingertip (30). Continuous record-
ings of arterial pulse pressure were obtained at a fingertip of the right
arm by means of a noninvasive cuff pressure recorder (Portapres;
FMS, Amsterdam, The Netherlands). Beat-by-beat mean arterial pres-
sure (P ) was computed as the integral mean of each pressure profile
using the Beatscope software package (FMS).
The stroke volume of the heart (Qst) was determined on a beat-by-
beat basis by means of the model flow method (53), applied off-line
to the pulse pressure profiles, again using the Beatscope software
package. Beat-by-beat Q̇ was computed as the product of single-beat
Qst times the corresponding single-beat fH. Correction for the inaccu-
racy of the method was applied as previously described (2, 27, 50). To
this purpose, steady-state Q̇ values also were obtained by means of the
open-circuit acetylene method (4) using a procedure that was previ-
ously described (27). Individual correction factors at rest and at each
workload were calculated as previously described (27) and also
applied during dynamic states with rapid changes in Q̇ (51).
Exercise was carried out on an electrically braked cycle ergometer
(Ergometrics 800-S; Ergoline, Bitz, Germany). The pedaling fre-
quency was recorded, and its sudden increase at the exercise onset and
decrease at the exercise offset were used as markers to identify
precisely the start and the end of exercise. The electromechanical
characteristics of the ergometer were such as to permit workload
application in 50 ms. All the signals were digitalized in parallel by
a 16-channel analog-to-digital converter (MP100; Biopac Systems,
Goleta, CA) and stored on a computer. The acquisition rate was
100 Hz.
Blood hemoglobin concentration ([Hb]) was measured using a
photometric technique (HemoCue, Ängelholm, Sweden) on 10-l
blood samples from a peripheral venous line inserted in the left
forearm. Blood lactate concentration ([La]b) was measured using an
electroenzymatic method (Eppendorf EBIO 6666, Erlangen, Ger-
many) on 20-l blood samples from the same venous line. Arterial
blood gas composition was measured with microelectrodes (Instru-
mentation Laboratory Synthesis 10, Lexington, MA) on 300-l blood
samples taken from an arterial catheter inserted in the left radial
artery.
Protocol. Experiments were first performed in normoxia and then
in acute normobaric hypoxia (fraction of inspired O2, 0.11; inspired
O2 partial pressure, 80 mmHg). In hypoxia, inspired gas was admin-
istered from high-pressure gas cylinders via an 80-liter Douglas bag
buffer. The fraction of inspired O2 was monitored on the inspiratory
line, close to the mouth. The gas flow from the cylinders was
continuously adjusted to the subject’s ventilation. Experiments in
hypoxia were preceded by a 10-min period for gas store equilibration.
The experimental protocol started with the performance of blood
sampling and the measurement of acetylene Q̇ at rest, and then 2 min
of quiet resting recordings were allowed, after which the exercise at
50 W started, for a duration of 10 min. Arterial blood gas composition
and [La]b were measured at minute 5 and at the end of exercise. At
minute 7, the measurement of Q̇ with the acetylene technique was
initiated. The 50-W exercise was followed by a 10-min recovery,
during which [La]b was measured at minutes 2, 4, and 6, and arterial
blood gas composition was determined at minutes 5 and 10. The
100-W exercise was then carried out, for a 10-min duration, and with
the same timing of events as at 50 W. A 10-min recovery followed,
with the same characteristics as the previous one. The overall duration
of this protocol was about 60 min, during which [Hb] was systemat-
ically measured at 1-min intervals.
Each subject repeated this protocol four times, in both normoxia
and hypoxia. At each repetition, the performance of blood sampling
for [Hb] determination was shifted by 15 s, as previously described
(27), to obtain, after superposition of the four tests, an overall
description of the changes in [Hb] on a 15-s time basis.
Data treatment. The superimposed time course of [Hb] was
smoothed by a four-sample mobile mean, to account for interrepeti-
tion variability, and interpolated by means of a 6th degree polynomial,
as previously described (27). The continuous SaO2 traces from the four
repetitions were temporally aligned and superimposed by means of an
ensemble average procedure. The resulting overall SaO2 trace was then
interpolated by means of a 6th degree polynomial. The resulting
functions, describing the time course of [Hb] and SaO2, were used to
compute the time course of arterial O2 concentration (CaO2, ml/l) on
an equivalent beat-by-beat time scale, established after the pulse
pressure profile traces, as in a previous study (27).
The beat-by-beat fH, Qst, P , and Q̇ values from the four repetitions
of each subject were aligned temporally by setting the time of exercise
start as time 0 for the analysis of on kinetics. The data were then
averaged on a beat-by-beat basis to obtain a single averaged, super-
imposed time series for each parameter and subject. Beat-by-beat Q̇a
O2
was then calculated as
Q̇aO2t  Q̇t  CaO2t (1)
Beat-by-beat total peripheral resistance (Rp) was calculated by
dividing each P value by the corresponding Q̇ value, on the assump-
tion that the pressure in the right atrium can be neglected as a
determinant of peripheral resistance.
Based on the conclusions arrived at in a previous study (27), the
kinetics of V̇O2, Q̇, and Q̇aO2 were described by means of a two-phase
model, whereby an exponential increase in flow (phase II) is preceded
by a faster flow increase in the first seconds of exercise (phase I),
which Barstow and Molé (5) also treated as an exponential. To
compute the characteristic parameters of the exponential equations
describing phase I, the four repetitions were interpolated to 1-s
intervals (28) and then aligned temporally, as described above, and
averaged to obtain a single superimposed time series (27). Since the
tested hypothesis concerns specifically a phenomenon that takes place
during phase I, in the results we report only the phase I parameters,
neglecting the phase II parameters, to which the tested hypothesis
does not pertain.
Statistics. Data are means and standard deviations of the values
obtained for each parameter from the average superimposed files of
each subject, to account for interindividual variability. The effects of
exercise intensity and hypoxia on the investigated parameters were
analyzed separately using a one-tailed t-test for paired observations.
Bonferroni correction was then applied. The parameters of the models
were estimated by utilizing a weighted nonlinear least squares proce-
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dure (10), implemented under Labview (version 5.0; National Instru-
ments, Austin TX). Initial guesses of the parameters of the model
were entered after visual inspection of the data. The effects of exercise
intensity and hypoxia on these values were investigated using a
one-tailed t-test for paired observations. The results were considered
significant if P  0.025.
RESULTS
The [Hb], SaO2, and CaO2 values at rest and at the exercise
steady state are reported in Table 1, together with arterial blood
pH, PO2, and PCO2. The SaO2 and CaO2 values in hypoxia were
lower than the corresponding values in normoxia. Arterial
blood pH was higher in hypoxia than in normoxia and was
unaffected by the exercise intensity in both conditions. PO2 and
PCO2 were both lower in hypoxia than in normoxia. In the
latter, they did not vary at exercise. In hypoxia, PO2 decreased
during exercise (P  0.025) and PCO2 tended to decrease (not
significant, NS). In normoxia, [La]b was 1.3  0.3 mM at rest
and did not change at exercise. In hypoxia, [La]b was 2.0  0.5
mM at rest and 2.3  0.5 mM at 50 W (NS). At 100 W, [La]b
increased to 3.7  1.3 mM at minute 5 and 4.5  1.7 mM at
minute 10.
The mean values for Q̇, fH, Qst, P , Rp, Q̇aO2, and V̇O2,
obtained at rest and at the exercise steady state at both powers,
are reported in Table 2. At all metabolic powers, fH was higher
in hypoxia than in normoxia. Qst was the same in hypoxia as in
normoxia so that Q̇ resulted systematically higher in hypoxia
than in normoxia. At rest, P was lower in hypoxia than in
normoxia, but this difference disappeared at exercise. As a
consequence, systematically lower Rp values were found in
hypoxia than in normoxia (NS at rest, P  0.025 at 50 and
100 W). Q̇aO2 was not significantly different from normoxia at
rest. At 50 and 100 W, however, Q̇aO2 turned out lower in
hypoxia than in normoxia. V̇O2 was the same in hypoxia as in
normoxia.
The time courses of fH, Qst, Q̇, P , and Rp upon the onset of
50- and 100-W exercise are shown in Fig. 1. Beat-by-beat data
collected in the 15 s that preceded and in the 45 s that followed
the start of exercise are shown in Fig. 1, to draw attention to
phase I events. In normoxia, a steady state for fH appeared as
soon as phase I was completed at 50 W, whereas a clear slower
phase II increase was evident at 100 W. In hypoxia, the relative
contribution of phase I to the fH response was less than in
normoxia. The time course of Qst was the same in hypoxia as
in normoxia. Thus the initial change of Q̇ in hypoxia, compared
with normoxia, followed essentially the same patterns as for fH.
The increase in P was modest and slow, in both normoxia and
hypoxia. Conversely, Rp underwent a sudden dramatic de-
crease, the amplitude of which was smaller in hypoxia than in
normoxia.
The evolution of beat-by-beat fH as a function of beat-by-
beat P is shown in Fig. 2. For both normoxia and hypoxia, the
resting values are located on the lower left side of the plot, and
the exercise steady-state values are located on the upper right
side. However, the resting values in hypoxia were displaced
upward and leftward with respect to those in normoxia, as were
the exercise values. In normoxia, at both workloads, the
pattern of displacement of the baroreflex operational point
from rest to exercise was dictated by the rapid increase in fH,
as demonstrated by the small number of points required to
attain the cluster of the fH and P values at exercise. Similar
patterns were observed in hypoxia, although 1) the size of
the displacement of baroreflex operational point was larger
than in normoxia, and 2) the number of beats required to
complete this displacement in hypoxia (within 30 and 60
beats at 50 and 100 W, respectively) was greater (slower
increase) than in normoxia (within 20 and 45 beats at 50 and
100 W, respectively).
In normoxia, since SaO2 was unchanged, the evolution of
CaO2 followed the changes in [Hb]. In hypoxia, CaO2 under-
went larger changes than in normoxia, which were dictated not
only by the changes in [Hb] but also by the decrease in SaO2 in
the exercise transient. In hypoxia, a steady CaO2 level lower
than at rest was attained within 2 min.
The time courses of Q̇aO2 and V̇O2 upon the onset of 50- and
100-W exercise are reported in Fig. 3. The rate of readjustment
Table 1. Oxygen, hemoglobin, and pH in arterial blood
Workload Rest 50 W 100 W
Normoxia
[Hb], g/l 147.410.0 149.89.7 153.410.6
SaO2 0.9650.007 0.9650.004 0.9560.012
CaO2, ml/l 190.512.7 193.712.1 196.411.6
pH 7.410.01 7.420.01 7.410.01
PaO2, mmHg 85.83.9 88.63.2 86.42.1
PaCO2, mmHg 38.41.6 36.81.6 37.72.4
Hypoxia
[Hb], g/l 151.99.3 153.110.8 155.510.9
SaO2 0.6760.046* 0.6080.055* 0.5780.075*
CaO2, ml/l 137.714.5* 121.534.9* 121.022.4*
pH 7.470.02* 7.480.02* 7.480.02*
PaO2, mmHg 39.55.1* 35.23.3* 33.22.9*
PaCO2, mmHg 31.72.2* 30.92.3* 27.91.9*
Values are means 	 SD of steady-state values. [Hb], blood hemoglobin
concentration; SaO2, arterial O2 saturation; CaO2, arterial O2 concentration;
PaO2, arterial partial pressure of O2; PaCO2, arterial partial pressure of CO2.
*P  0.25, significantly different from corresponding value in normoxia.
Table 2. Steady-state values of cardiopulmonary parameters
at rest and at exercise at 50 and 100 W
Workload Rest 50 W 100 W
Normoxia
Q̇, l/min 6.840.20 12.060.30 14.880.38
fH, min
1 74.51.8 98.81.2 114.21.4
Qst, ml 93.32.3 122.72.8 131.73.4
Q̇aO2, l/min 1.300.04 2.350.06 2.920.07
V̇O2, l/min 0.540.06 1.450.06 1.790.03
P , mmHg 90.11.7 101.31.3 104.32.5
Rp, mmHg min  l
1 13.770.51 8.660.28 7.280.28
Hypoxia
Q̇, l/min 8.580.37* 15.320.37* 19.510.52*
fH, min
1 87.82.1* 121.61.6* 141.82.0*
Qst, ml 97.33.4 126.12.6 136.83.5
Q̇aO2, l/min 1.300.05 1.990.05* 2.380.06*
V̇O2, l/min 0.600.10 1.370.13 1.890.11
P , mmHg 83.61.3* 95.21.7 101.71.4
Rp, mmHg min  l
1 10.840.53 6.640.21* 5.700.17*
Values are means 	 SD of single-beat values over 1 min at rest and exercise
steady state. Q̇, cardiac output; fH, heart rate; Qst, stroke volume; Q̇aO2,
systemic O2 delivery; V̇O2, O2 uptake; P , mean arterial pressure; Rp, peripheral
resistance. *P  0.025, significantly different from corresponding value in
normoxia.
R626 OXYGEN FLOW KINETICS IN HYPOXIA
AJP-Regul Integr Comp Physiol • VOL 295 • AUGUST 2008 • www.ajpregu.org
 on N
ovem






of V̇O2 followed the same trend in hypoxia as in normoxia. In
normoxia, it was slower than that of Q̇aO2. This difference
disappeared in hypoxia, because the rate of readjustment of Q̇aO2
was slower in hypoxia than in normoxia.
The characteristic parameters describing the Q̇, Q̇aO2, V̇O2,
and fH kinetics during phase I are presented in Table 3. For
V̇O2, amplitude of phase I (A1) was the same in hypoxia as in
normoxia. For Q̇ and Q̇aO2, A1 was significantly lower in
Fig. 1. Time course of investigated cardiovascular parame-
ters upon the onset of exercise at 50 and 100 W in normoxia
and hypoxia. Values are shown for heart rate, stroke volume,
cardiac output, mean arterial pressure, and total peripheral
resistance (TPR). Each value is the mean of the averaged
superimposed values of all subjects. Time 0 corresponds to
the start of exercise.
R627OXYGEN FLOW KINETICS IN HYPOXIA
AJP-Regul Integr Comp Physiol • VOL 295 • AUGUST 2008 • www.ajpregu.org
 on N
ovem






hypoxia than in normoxia. In both normoxia and hypoxia, A1
was the same at 100 W as at 50 W. For Q̇aO2 and V̇O2, 1 was
unaffected by hypoxia. For Q̇, 1 was shorter in hypoxia than
in normoxia at 50 W but not at 100 W. For fH, A1 was lower
in hypoxia than in normoxia at 50 W but not at 100 W. In
normoxia, A1 was the same at 50 W as at 100 W, as it was in
hypoxia. 1 was higher in hypoxia than in normoxia at 100 W
but not at 50 W. In hypoxia, 1 was significantly greater at 100
W than at 50 W.
DISCUSSION
This study was carried out to test the hypothesis that vagal
withdrawal determines the phase I kinetics of Q̇, Q̇aO2, and V̇O2
at exercise onset. This hypothesis implies that phase I would be
either absent or eventually less intense compared with nor-
moxia. The main finding of this study is that the amplitude of
the phase I (A1) of the kinetics of Q̇ and Q̇aO2 at exercise onset
was smaller in acute normobaric hypoxia, wherein reduced
vagal activity (8, 26) and increased sympathetic activity at rest
have been postulated (21, 26, 58, 59), than in normoxia,
whereas its time constant 1 was unchanged. No differences
appeared concerning the phase I of V̇O2 kinetics. In hypoxia,
the reductions in A1 are coherent with the concept of a lesser
effect of postulated vagal withdrawal at exercise onset.
Steady-state data. The increased sympathetic activity to the
heart in acute hypoxia (21, 22, 44, 45), perhaps through
peripheral chemoreceptor stimulation (22), may be sufficient to
explain the higher fH in hypoxia than in normoxia, both at rest
and at any given work level. Since Qst is unaffected by acute
hypoxia, the increase in fH entails a corresponding increase in
Q̇, as already demonstrated in several studies (1, 23, 49). The
present data (see Table 2) are in full agreement with this
picture.
A larger sympathetic activity, if directed to peripheral ves-
sels as well, might also imply peripheral vasoconstriction and,
hence, a greater Rp in hypoxia than in normoxia. However, this
was not so in the present study, since Rp (Table 2) was lower
in hypoxia than in normoxia, whether at rest or at the two
investigated workloads, because a higher Q̇ was associated
with an unchanged P . Rp was rarely looked at in hypoxia in the
past, yet it was possible to compute it from some studies (1, 23,
49). The obtained data are coherent with those of the present
study. Moreover, increased peripheral sympathetic activation
in hypoxia, though providing a potent peripheral vasoconstric-
tion stimulus, is not accompanied by increased leg vascular
resistance at rest, which was rather found to be reduced
compared with normoxia (22).
This apparent contradiction may be explained by admitting
either of these three hypotheses : 1) hypoxemia reduces the
sensitivity and increases the activation threshold of vascular
sympathetic receptors (sympatholysis); 2) hypoxemia superim-
poses a vasodilating stimulus in peripheral circulation; or 3) the
intensity and quality of sympathetic output may differ among
various target organs in hypoxia. The first hypothesis was
recently contradicted by the demonstration that the vascular
response to tyramine is not reduced in hypoxia (56). The two
other hypotheses were supported by the observation of 2-
mediated vasodilatation in resting skeletal muscle in hypoxia
due to increased adrenaline release (52). Peripheral O2 sensing
mechanisms may be implied in this effect. For instance, ac-
cording to Stamler et al. (48), the conformation of the reduced
hemoglobin determines the rise of nitric oxide (NO) in blood
with consequent vasodilatation. In contradiction to this, how-
ever, Weisbrod et al. (52) failed to show a reduction of
peripheral hypoxic vasodilatation after NO synthase blockade.
Other SaO2-related mechanisms were postulated, which would
imply ATP-mediated vasodilatation (32). A clear picture of the
events that lead to decreased Rp is still far from being estab-
lished.
Phase I kinetics. The hypothesis that vagal withdrawal
determines phase I relies essentially on observations made on
fH upon exercise onset in normoxia, the kinetics of which were
similar in this and previous studies (6, 18, 37, 46). In fact, the
fast component of fH kinetics 1) was cancelled out under vagal
blockade (18) and 2) was not found in heart transplant recip-
ients, whose hearts are denervated (3, 20, 40). To extend this
hypothesis to explain phase I kinetics of Q̇, Q̇aO2, and V̇O2, we
should be able to demonstrate that when vagal tone is attenu-
ated, as is the case in acute normobaric hypoxia (26), the phase
I should either be reduced or disappear for all these parameters.
Indeed, hypoxia reduced A1 significantly, for Q̇ and Q̇aO2
(Table 3) at both 50 and 100 W and for fH at 50 W, but did not
extinguish it. On the other hand, hypoxia acted very little on 1,
Fig. 2. Beat-by-beat heart rate as a function of the corresponding beat-by-beat
mean arterial pressure (Pmean) upon the onset of exercise at 50 and 100 W in
normoxia and hypoxia. The resting values are located on at bottom left; the
exercise steady-state values are at top right. The resting values in hypoxia are
displaced upward and leftward with respect to the corresponding values in
normoxia. The pattern of displacement of the heart rate vs. Pmean operational
range from rest to exercise is completed, at 50 W, within 20 and 30 beats, and
at 100 W, within 45 and 60 beats, in normoxia and hypoxia, respectively.
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whose very low values were essentially invariant; we noticed
only a reduction at 50 W for Q̇ and an increase at 100 W for
fH. This would mean that 1) the 1 values in hypoxia also are
compatible with a very rapid neural phenomenon, vagal with-
drawal, as originally proposed by Fagraeus and Linnarsson
(18) for normoxia; 2) vagal withdrawal has a smaller amplitude
in hypoxia than in normoxia because of lesser vagal activation
in the former; and 3) the patterns in the time domain of vagal
withdrawal at exercise onset are fixed and invariant.
However, the occurrence of phase I in hypoxia with a
smaller amplitude, instead of a full suppression of it, may
imply that 1) hypoxia did not fully suppress vagal activity at
rest so that some degree of vagal withdrawal still took place at
exercise onset, or 2) other mechanisms than vagal withdrawal
participate in phase I. The former may indeed be the case for
fH. The latter is suggested by the apparent lack of changes in
the Qst kinetics in hypoxia with respect to normoxia (Fig. 1). In
the absence of a clear predetermined model for the Qst kinetics,
whereby we refrained from fitting parameters through Qst data,
we evaluated the contribution of Qst to Q̇ A1, as follows. Since
Q̇ is the product of fH times Qst, the absolute Q̇ value at the peak
of phase I is equal to
Q̇  Q̇   fH  fH  Qst  Qst (2)
where Q̇, fH, and Qst are the resting values and Q̇, fH, and
Qst are the corresponding increments during phase I, namely,
the respective A1 values. Solution of this equation for Qst
thus provides an estimate of the Qst amplitude during phase I
that is necessary to sustain the observed increase in Q̇. At 50
W, Qst was 23.9  10.5 and 14.7  7.1 ml in normoxia and
hypoxia, respectively. The corresponding Qst values at 100 W
were 33.1  9.3 and 24.2  21.2 ml. At both powers, although
affected by a large scatter, Qst did not differ in hypoxia from
normoxia (P  0.1 in both cases), suggesting that, contrary to
fH, the alleged amplitude of Qst in phase I may not vary in
hypoxia with respect to normoxia. This being the case, then
1) if indeed the reduction of the A1 of fH in hypoxia is due to
lesser vagal withdrawal, then the same should be the case for
Fig. 3. Time course of arterial O2 flow (ox-
ygen delivery, Q̇aO2) and lung O2 uptake
(V̇O2) upon the onset of exercise at 50 and
100 W in normoxia and hypoxia. Each value
is the mean of the averaged superimposed
values of all subjects. Time 0 corresponds to
the start of exercise.
Table 3. Kinetics of systemic O2 delivery, O2 uptake,
and cardiac output within the two-phase model
50 W 100 W
A1, l/min 1, s A1, l/min 1, s
Q̇
Normoxia 4.570.61 3.141.91 5.241.26 3.391.66
Hypoxia 2.520.90* 1.570.64* 3.711.75* 5.754.09§
Q̇aO2
Normoxia 0.700.07 2.811.43 0.720.19 2.381.81
Hypoxia 0.380.16* 2.200.86 0.360.08* 3.221.61
V̇O2
Normoxia 0.390.14 0.550.58 0.520.11 1.561.68
Hypoxia 0.350.07 2.360.59 0.450.17 3.140.68
fH
Normoxia 22.443.00 2.821.31 22.929.45 2.642.11
Hypoxia 14.505.59* 2.081.88 20.7213.29 4.462.26*§
Data are means  SD. A1, amplitude of phase I change; 1, time constant of
phase I. *P  0.025, significantly different from corresponding value in normoxia.
§P  0.025, significantly different from corresponding value at 50 W.
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the reduction of the A1 of Q̇; and 2) the Qst changes during an
exercise transient are independent of mechanisms related to
vagal withdrawal. Concerning the latter, in supine posture, a
condition in which central blood volume is increased (24, 29,
47), phase I of Q̇ is not evident (25, 29), although resting vagal
activation is greater supine than upright (25, 38). A higher
central blood volume would reduce the amount of blood
suddenly displaced from the periphery to the heart by muscle
pump action, and thus the size of the immediate increase in
venous return, thus preventing an efficient Frank-Starling
mechanism. In the present study exercise was carried out in
upright posture only, so it is likely that the increase in venous
return due to muscle pump action would be the same in
hypoxia as in normoxia, whence equivalent Qst kinetics.
In both normoxia and hypoxia, the 1 of V̇O2 kinetics was
extremely rapid and functionally instantaneous, indicating a
practically immediate upward translation of V̇O2 that appears
since the first breath. The 1 of V̇O2 did not differ between
powers and can be considered equal to those of Q̇ and Q̇aO2
(Table 3), given that the minimal functional time window in
which V̇O2 can be determined is one breathing cycle. This
suggests that the phase I changes in V̇O2 are imposed by the
corresponding phase I changes in Q̇. Because of a delay
between muscle O2 consumption and V̇O2, we can assume that
during the first seconds of exercise, arterial-venous O2 differ-
ence (CaO2-CvO2) remains equal to that at rest (5). On this
basis, the Fick principle allows a prediction of the expected
V̇O2 increase in phase I as a consequence of the observed Q̇
increase. In normoxia, A1 of Q̇ was on average 4.57 l/min (see
Table 3). For an average resting CaO2-CvO2 of 79 ml/l, we
would expect an immediate V̇O2 increase upon exercise start of
0.36 l/min, compared with a measured A1 of V̇O2 of 0.39 l/min
(Table 3). By analogy, in hypoxia, A1 of Q̇ was on average
2.52 l/min (Table 3), and the resting CaO2-CvO2 was 70 ml/l.
Thus the expected V̇O2 increase would be 0.18 l/min, compared
with a measured A1 of V̇O2 of 0.35 l/min (Table 3). Despite this
sizeable discrepancy, the two values are not significantly dif-
ferent, probably because of the relatively large coefficient of
variation of the data in hypoxia. Nevertheless, the results of
this analysis suggest that A1 of V̇O2 may be a direct conse-
quence of the rapid Q̇ increase during phase I, in agreement
with the so-called cardiodynamic hypothesis of lung V̇O2
transients (55).
Baroreflex resetting. At rest in normoxia, P was 90 mmHg
and fH was 74.5 min-1. Let us assume that these values set the
operating point of the average baroreflex curve of present
subjects and that the operating point of resting subjects in
normoxia corresponds to the centering point of the baroreflex
curve (42). Assume also that the maximal gain and the oper-
ating range of the baroreflex curve are as previously reported
(36). On this basis, we can construct a resting baroreflex
response curve for the present subjects, which is reported in
Fig. 4. If we then add the average resting value observed in
hypoxia to that curve, we can see that the subjects operated
in hypoxia on the same baroreflex curve as in normoxia, with
a displacement of the operating point along the curve toward
the threshold. This is a result of the decrease in P induced by
peripheral vasodilation, to which the subjects responded with
an increase in fH, supporting the notion that peripheral vascular
changes play a significant role in the baroreflex response of
resting humans (17, 35). If indeed hypoxemia induces vasodi-
lation in peripheral circulation via 2-sympathetic stimulation,
then we can propose a role for peripheral chemoreflexes in the
displacement of the baroreflex operating point in hypoxia.
Exercise displaces the baroreflex curve upward and right-
ward, without changes in gain [baroreflex resetting (42)]. This
phenomenon is part of the rapid cardiovascular response upon
exercise start. Baroreflex resetting includes a fast phase (Fig.
2), completed within a few heartbeats, within the duration of
phase I, which goes on in parallel with the rapid changes in Rp
that take place at exercise start. However, the dynamics of
baroreflex resetting implied a larger number of heartbeats in
hypoxia than in normoxia. If vagal withdrawal sets phase I of
fH, then it will also contribute to the rapid upward shift of the
baroreflex curve, but its role in baroreflex resetting will be less
important in hypoxia than in normoxia.
Figure 4 also reports baroreflex curves for 50- and 100-W
exercises, which are shifted upward as much as described in
previous studies (34, 35, 39, 41). When the 50- and 100-W
steady-state P and fH values were added to Fig. 4, they were
further displaced upward and rightward with respect to the
predicted exercise baroreflex curve, suggesting that in the
present study, baroreflex resetting was somewhat more in-
tense than previously reported. Moreover, at both 50 and
100 W, the segment relating the experimental point in
normoxia to the experimental point in hypoxia had a greater
slope than the expected baroreflex gain, suggesting that the
latter experimental point may lie on a different baroreflex
curve than the former in both cases. A 50-W exercise
provides a higher power relative to the maximum in hypoxia
Fig. 4. Baroreflex response curve at rest and exercise steady state. Heart
rate (fH) as a function of mean arterial pressure (P ). Theoretical baroreflex
curves are shown for rest (solid curve), exercise at 50 W (shaded curve),
and exercise at 100 W (dashed curve). The curve at rest was constructed
using the present mean resting values of P to define the baroreflex operating
point and assuming 1) that the operating point of resting subjects in
normoxia corresponds to the center point (42) and 2) that the maximal gain
and the operating range of the baroreflex curve are as previously reported
(36). The two curves at exercise were built by shifting the former upward by
an amount equal to the average reported in previous studies (34, 35, 39, 41),
assuming that the gain and operating ranges do not change at exercise steady
state. The average steady-state values observed at rest (solid circles), exercise
at 50 W (shaded circles), and exercise at 100 W (open circles) in normoxia and
hypoxia are also indicated. At rest, the point in hypoxia is displaced upward
and leftward, on the corresponding theoretical baroreflex curve. At exercise,
the points do not lie on the corresponding theoretical baroreflex curve but are
further displaced upward and rightward.
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than in normoxia because of the decrease in maximal O2
uptake in hypoxia, whereby implying a greater role of the
chemical component of the exercise pressor reflex (42). Yet we
cannot distinguish the relative roles of central command or of
the exercise pressor reflex in determining baroreflex resetting
from the present data (42).
Conclusions. We conclude that in hypoxia, with respect to
normoxia, 1) phase I is not completely suppressed for fH,
although the A1 for fH is decreased, likely because the degree
of vagal withdrawal is less; 2) since phase I is partly main-
tained, arterial baroreflex resetting continues to be very rapid,
taking place essentially within phase I; 3) Qst is unchanged,
because the increase in venous return due to muscle pump
action is unchanged; 4) the coupling of a decreased A1 for fH
with an unchanged Qst would produce the observed decrease
in A1 of Q̇; and 5) the same factors that determine the phase I
of Q̇ are also responsible for the phase I of V̇O2. Thus the
present results provide only partial support to the hypothesis
that vagal withdrawal determines the phase I kinetics of car-
diovascular O2 flow and lung O2 uptake, because the suppres-
sion of phase I was incomplete. Although we can attribute the
decrease in A1 of fH to a diminished degree of vagal with-
drawal in hypoxia, this is not so for Qst. Under these circum-
stances, the dual origin of the phase I of Q̇ and Q̇aO2, neural
(vagal) and mechanical (increase in venous return by muscle
pump action), would rather be confirmed.
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37. Orizio C, Perini R, Comandé A, Castellano M, Beschi M, Veicsteinas
A. Plasma catecholamines and heart rate at the beginning of muscular
exercise in man. Eur J Appl Physiol 57: 644–651, 1988.
38. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P,
Sandrone G, Malfatto G, Dell’Orto S, Piccaluga E, Turiel M, Baselli
G, Cerutti S, Malliani A. Power spectral analysis of heart rate and arterial
pressure variabilities as a marker of sympatho-vagal interaction in man
and conscious dog. Circ Res 59: 178–193, 1986.
39. Papelier Y, Escourrou P, Gauthier JP, Rowell LB. Carotid baroreflex
control of blood pressure and heart rate in men during dynamic exercise.
J Appl Physiol 77: 502–506, 1994.
40. Perini R, Orizio C, Gamba A, Veicsteinas A. Kinetics of heart rate and
catecholamines during exercise in humans. The effect of heart denerva-
tion. Eur J Appl Physiol 66: 500–506, 1993.
41. Potts JT, Shi XR, Raven PB. Carotid baroreflex responsiveness during
dynamic exercise in humans. Am J Physiol Heart Circ Physiol 265:
H1928–H1938, 1993.
42. Raven PB, Fadel PJ, Ogoh S. Arterial baroreflex resetting during exer-
cise: a current perspective. Exp Physiol 91: 37–49, 2006.
43. Rossiter HB, Ward SA, Doyle VL, Howe FA, Griffiths JR, Whipp BJ.
Inferences from pulmonary O2 uptake with respect to intramuscular
[phosphocreatine] kinetics during moderate exercise in humans. J Physiol
518: 921–932, 1999.
44. Rowell LB, Johnson DG, Chase PB, Comess KA, Seals DR. Hypoxemia
raises muscle sympathetic activity but not norepinephrine in resting
humans. J Appl Physiol 66: 1736–1743, 1989.
45. Saito M, Mano S, Iwase K, Koga K, Abe H, Yamazaki Y. Responses in
muscle sympathetic activity to acute hypoxia in humans. J Appl Physiol
65: 1548–1552, 1988.
46. Sietsema KE, Daly JA, Wasserman K. Early dynamics of O2 uptake and
heart rate as affected by exercise work rate. J Appl Physiol 67: 2535–2541,
1989.
47. Spaak J, Montmerle S, Sundblad P, Linnarsson D. Long-term bed
rest-induced reductions in stroke volume during rest and exercise: cardiac
dysfunction vs. volume depletion. J Appl Physiol 98: 648–654, 2005.
48. Stamler JS, Jia L, Eu JP, Mcmahon TJ, Demchenko IT, Bonaventura
J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemo-
globin in the physiological oxygen gradient. Science 276: 2034–2037,
1997.
49. Stenberg J, Ekblom B, Messin R. Hemodynamic response to work at
simulated altitude, 4000 m. J Appl Physiol 21: 1589–1594, 1966.
50. Tam E, Azabji Kenfack M, Cautero M, Lador F, Antonutto G, di
Prampero PE, Ferretti G, Capelli C. Correction of cardiac output
obtained by Modelflow from finger pulse pressure profiles with a respi-
ratory method in humans. Clin Sci (Lond) 106: 371–376, 2004.
51. Van Lieshout JJ, Toska K, Van Lieshout EJ, Eriksen M, Walloe L,
Wesseling KH. Beat-to-beat non-invasive stroke volume from arterial
pressure and Doppler ultrasound. Eur J Appl Physiol 90: 131–137, 2003.
52. Weisbrod CJ, Minson CT, Joyner MJ, Halliwill JR. Effects of regional
phentolamine on hypoxic vasodilatation in healthy humans. J Physiol 537:
613–621, 2001.
53. Wesseling KH, Jansen JR, Settels JJ, Schreuder JJ. Computation of
aortic flow from pressure in humans using a nonlinear, three-element
model. J Appl Physiol 74: 2566–2573, 1993.
54. Whipp BJ, Ward SA. Physiological determinants of pulmonary gas
exchange kinetics during exercise. Med Sci Sports Exerc 22: 62–71, 1990.
55. Whipp BJ, Wasserman K. Effect of anaerobiosis on the kinetics of O2
uptake during exercise. Fed Proc 45: 2942–2947, 1986.
56. Wilkins BW, Schrage WG, Liu Z, Hancock KC, Joyner MJ. Systemic
hypoxia and vasoconstrictor responsiveness in exercising human muscle.
J Appl Physiol 101: 1343–1350, 2006.
57. Williamson JW, Fadel PJ, Mitchell JH. New insights into central
cardiovascular control during exercise. Exp Physiol 91: 51–58, 2006.
58. Xie A, Skatrud JB, Puleo DS, Morgan BJ. Exposure to hypoxia
produces long-lasting sympathetic activation in humans. J Appl Physiol
91: 1555–1562, 2001.
59. Yamamoto Y, Hoshikawa Y, Miyashita M. Effects of acute exposure to
simulated altitude on heart rate variability during exercise. J Appl Physiol
81: 1223–1229, 1996.
60. Yoshida T, Whipp BJ. Dynamic asymmetries of cardiac output transients
in response to muscular exercise in man. J Physiol 480: 355–359, 1994.
R632 OXYGEN FLOW KINETICS IN HYPOXIA
AJP-Regul Integr Comp Physiol • VOL 295 • AUGUST 2008 • www.ajpregu.org
 on N
ovem
ber 14, 2008 
ajpregu.physiology.org
D
ow
nloaded from
 
